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Purpose/Objective(s)
To compare the uncertainties of 3D dose distributions, caused by the
geometrical uncertainty of patient setup, in IMRT, VMAT, and proton
plans for post-prostatectomy treatment. To test the effectiveness of a
common margin recipe in these three types of treatment plans.

Material/Methods
Four prostate fossa patient datasets were included. For each case,
three different plans were carried out: an IMRT plan of nine fields
(XiO, Elekta), a VMAT plan, and a proton plan with two lateral active
scanning beams (Oncentra, Nucletron). The plan robustness analysis
function in CERR (Washington University, St. Louis, MO) software
was used to simulate the DVH uncertainty with given systematic
(Σ) and random (σ) shifts in three dimensions. Five different
combinations of Σ (2-4mm) and σ (2-4mm) representing clinical
situations were used for all plans. The DVH uncertainty range (upper
and lower bounds) was generated by CERR for each setting of Σ and
σ with a certain confidence level (95% was used in this study). We
tested CTV coverage using a common margin recipe (2.5 Σ + 0.7 σ)
for all IMRT, VMAT, and proton plans.

V95% was larger than 99.4% in all plans with the estimated Σ and σ
from the margin recipe, showing the effectiveness of the margin
recipe for IMRT, VMAT, and proton plans included in this study.

Conclusion
In this simulation of potential setup uncertainties, larger variation in
DVH for bladder and rectum were observed with proton plans than
with IMRT and VMAT plans, to the extent that might compromise
the advantage of proton plans. The common margin recipe was
validated as a method to assure adequate target volume coverage for
IMRT, VMAT and proton plans studied.

Results
More than 98% of PTV was covered by 95% of prescription dose
in all plans. The upper bound of PTV V95% was close to 100% in all
plans for all Σ and σ settings. The mean values of lower bound of PTV
V95% were 85.4%, 85.0%, and 87.5% for IMRT, VMAT, and proton
plans, respectively (p=0.03 for IMRT vs. proton, paired samples t-test;
p=0.01 for VMAT vs. proton; p=0.36 for IMRT vs. VMAT). The mean
values of ranges (upper minus lower bound) for rectum V45Gy were
7.5% (IMRT), 7.5% (VMAT), 15.6% (proton), and the mean values
of ranges for bladder V40Gy were 6.2% (IMRT), 9.2% (VMAT), 12.7%
(proton). The proton plans exhibited significantly wider range of
rectum and bladder DVHs than the other two treatment techniques
(p<0.05 for both). Even though the proton plans had lower rectum
and bladder doses as compared with IMRT and VMAT, with the
uncertainty, the upper bounds were approaching similar doses from
IMRT and VMAT. Analysis of PTV V100%, rectum V56Gy, bladder
V56Gy showed similar comparison results. The lower bound of CTV
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